Study guide

14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity

IJCAHPO Certified Ophthalmic Medical Technologist COMT

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The COMT Examination, Eligibility & Certification Requirements

1.1 The 190-Question Multiple-Choice Examination & the 22 Official Content Areas 1.2 The COT Skill Evaluation & the COMT Performance Test 1.3 Eligibility Pathways, Fees, Timelines & Recertification

2 Chapter 2: General Medical Knowledge I — Ocular Anatomy & Physiology

2.1 Orbit, Eyelids, Lacrimal System, Conjunctiva & Extraocular Muscles 2.2 Cornea, Sclera, Anterior Chamber, Angle, Aqueous Dynamics & Crystalline Lens 2.3 Uvea, Retina, Vitreous, Optic Nerve, Ocular Circulation & the Visual Pathway

3 Chapter 3: General Medical Knowledge II — Eye Disease, Systemic Manifestations, Terminology & Safety

3.1 Frequently Encountered Eye Conditions by Structure & Inflammation Versus Infection 3.2 Body Systems & the Ocular Manifestations of Systemic Disease 3.3 Medical Terminology, Approved Abbreviations, Hazardous Waste & Clinic Safety

4 Chapter 4: Ophthalmic History Taking & Clinical Documentation

4.1 The Five History Domains: Ocular, Medical, Medication, Social & Family 4.2 Charting Conventions, Scribing & the Electronic Medical Record

5 Chapter 5: Visual Assessment, Accommodative Testing & Low Vision

5.1 Measuring Acuity at Every Level & in Preliterate, Illiterate and Non-Verbal Patients 5.2 Stereoacuity, Near Point of Accommodation, Near Point of Convergence & the AC/A Ratio 5.3 Low Vision Assessment, Magnification Calculation & Device Instruction

6 Chapter 6: Tonometry, Keratometry & Pupil Measurement

6.1 Goldmann Applanation Tonometry: Technique, Sources of Error & the Imbert-Fick Principle 6.2 Hand-Held Applanators, Non-Contact Tonometry, Rebound Tonometry & Disinfection 6.3 Manual & Automated Keratometry: Technique, Readings and Interpretation 6.4 Pupil Measurement, Shape, Reactivity & Evaluating Anisocoria

7 Chapter 7: Lensometry, Spectacle Optics & Prescription Analysis

7.1 Manual Lensometry: Eyepiece Focus, Neutralising Sphere, Cylinder & Axis 7.2 Neutralising Reading Adds: Bifocal, Trifocal, Progressive & Determining the Near Add 7.3 Identifying & Measuring Prism: Ground-In, Decentration, Fresnel Press-On & Slab-Off 7.4 Transposition, Spherical Equivalent, Vertex Distance & Prescription Components 7.5 The Geneva Lens Clock, Lens Materials, Progressive Markings & Spectacle Adjustment

8 Chapter 8: Refraction, Retinoscopy & Refinement

8.1 Autorefraction, Refractive Error Types & Establishing an Objective Starting Point 8.2 Streak Retinoscopy: With Motion, Against Motion, Neutralisation & Working Distance 8.3 Subjective Refinement: Fogging, Jackson Cross Cylinder, Duochrome & Binocular Balance 8.4 Near Add Determination, Vertex Recording & Refraction in Difficult Situations

9 Chapter 9: Ocular Motility, Strabismus & Advanced Optics

9.1 Ocular Kinematics: Ductions, Versions, Vergences, Hering's & Sherrington's Laws 9.2 Quantitative Strabismus Measurements: Alternate Cover Test, Prism Cover Test & Lancaster Red-Green / Hess Screen 9.3 Cranial Nerve Palsies (CN III, IV, VI), Restrictive Myopathies & Forced Duction Testing 9.4 Clinical Optics, Prentice's Rule, Slab-Off Prisms & Wavefront Aberrations

10 Chapter 10: Sensory Fusion Testing, Nystagmus, Amblyopia & Vergence Therapy

10.1 Sensory Fusion Testing: Worth 4-Dot, Maddox Rod & Bagolini Lenses 10.2 Hirschberg, Krimsky, Brückner & Fusional Vergence Amplitudes 10.3 Nystagmus, Amblyopia Therapy & Convergence Training

11 Chapter 11: Advanced Visual Fields & Neuro-Ophthalmic Evaluation

11.1 Amsler Grid & Confrontation Visual Field Testing 11.2 Automated Static Perimetry: HFA Strategies (SITA Standard, SITA Fast), Reliability Indices & Statpac Analysis 11.3 Visual Field Defect Patterns: Glaucomatous Nerve Fiber Bundle Deficits vs. Retinal Pathology 11.4 Kinetic Perimetry (Goldmann Perimetry) & Neurological Visual Pathway Defect Localization 11.5 Pupillary Pathways, RAPD Quantitation with Neutral Density Filters & Pharmacologic Testing

12 Chapter 12: Supplemental Testing — Glare, PAM, Colour Vision, Tear Film & Slit Lamp Technique

12.1 Glare Testing, Potential Acuity Meter & Contrast Sensitivity 12.2 Colour Vision: Pseudoisochromatic Plates, Farnsworth-Munsell D-15 & the 100-Hue Test 12.3 Tear Film Assessment: Schirmer, Tear Break-Up Time, Vital Dyes & Corneal Sensitivity 12.4 Slit Lamp Technique, Slit Lamp Lenses, Direct Ophthalmoscopy & Pen Light Examination 12.5 Exophthalmometry, Head & Posture Assessment and Wavefront Diagnostics

13 Chapter 13: Full-Field Electroretinography & ISCEV Protocols

13.1 Retinal Neurophysiology & Electrophysiologic Origin of Waveforms 13.2 ISCEV Standard Full-Field ERG Protocol & Electrode Systems 13.3 Dark-Adapted (Scotopic) Testing: Rod-Driven Responses & Combined Maximal Response 13.4 Light-Adapted (Photopic) Testing: Cone Response, 30-Hz Flicker & Oscillatory Potentials

14 Chapter 14: Advanced Electrophysiologic Testing (mfERG, PERG, VEP, EOG)

14.1 Multifocal Electroretinogram (mfERG): Topographic Retinal Mapping 14.2 Pattern Electroretinogram (PERG): Ganglion Cell & Macular Function 14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity 14.4 Electrooculogram (EOG), Arden Ratio & RPE Light Peak Dynamics

15 Chapter 15: Fluorescein Angiography Principles & Technique

15.1 Fluorescein Angiography Principles, Exciter/Barrier Filters & Injection Protocol 15.2 Normal Transit Phases & Retinal/Choroidal Circulation Hemodynamics 15.3 Adverse Reactions, Patient Safety & Emergency Management

16 Chapter 16: Angiographic Interpretation & Pathology

16.1 Hyperfluorescence Mechanisms: Leakage, Staining, Pooling, Window Defects & Autofluorescence 16.2 Hypofluorescence Mechanisms: Vascular Non-Perfusion & Blocking Defects 16.3 Indocyanine Green (ICG) Angiography: Principles, Indications & Choroidal Pathology

17 Chapter 17: Advanced Fundus Imaging & Optical Coherence Tomography

17.1 Fundus Autofluorescence (FAF) & Ultra-Widefield Fundus Imaging 17.2 Spectral-Domain and Swept-Source OCT: Retinal Layer Architecture & Quantitative Analysis 17.3 Enhanced Depth Imaging (EDI-OCT) & Anterior Segment OCT (AS-OCT) 17.4 Optical Coherence Tomography Angiography (OCTA): Chorioretinal Plexuses & Biomarkers

18 Chapter 18: Ophthalmic Photography & Videography

18.1 The Fundus Camera: Optics, Alignment & Correcting Artefacts 18.2 Standard Fundus Photography: ETDRS Fields, Stereo Pairs, Red-Free & Wide-Field Imaging 18.3 Slit Lamp & Anterior Segment Photography 18.4 External Photography, Nine-Gaze Motility Documentation & Image Management

19 Chapter 19: Ophthalmic Echography (A-Scan, B-Scan & UBM)

19.1 Physics of Ophthalmic Ultrasound, Acoustic Impedance & Probe Transducers 19.2 Standardized Diagnostic A-Scan: Acoustic Spikes, Tissue Reflectivity & Attenuation 19.3 Diagnostic B-Scan Echography: Topographic, Kinetic & Quantitative Vitreoretinal Evaluation 19.4 Ultrasound Biomicroscopy (UBM): Anterior Segment Anatomy, Angle Pathology & Ciliary Body Imaging

20 Chapter 20: Biometry, Topography & Corneal Analysis

20.1 Optical Biometry vs. Immersion/Contact Ultrasound Biometry 20.2 Intraocular Lens (IOL) Power Calculation Formulas & Post-Refractive Adjustments 20.3 Corneal Topography, Scheimpflug Tomography & Keratoconus Screening 20.4 Corneal Pachymetry, Endothelial Specular Microscopy & Anterior Chamber Depth

21 Chapter 21: Rigid Gas Permeable & Specialty Lens Fitting

21.1 Rigid Gas Permeable (RGP) Material Properties, Dk/t & Oxygen Permeability 21.2 RGP Base Curve Selection, Diagnostic Fitting & Fluorescein Pattern Evaluation 21.3 Scleral Contact Lens Design, Sagittal Depth Fitting & Clearance Evaluation 21.4 Keratoconus, Irregular Corneas & Hybrid Contact Lens Systems

22 Chapter 22: Toric, Multifocal, Therapeutic Lenses & Complications

22.1 Toric Soft Contact Lens Dynamics, Stabilization Techniques & LARS Rule 22.2 Presbyopic & Multifocal Contact Lens Systems: Simultaneous vs. Translating Designs 22.3 Therapeutic Bandage Contact Lenses, Amniotic Membranes & Orthokeratology 22.4 Contact Lens-Induced Pathology, Giant Papillary Conjunctivitis & Infectious Keratitis

23 Chapter 23: Ocular Pharmacology

23.1 Routes of Drug Delivery, Prescription Components & Instillation Technique 23.2 Mydriatics, Cycloplegics, Anaesthetics & Diagnostic Agents 23.3 Glaucoma Medications: Classes, Mechanisms & Side Effects 23.4 Anti-Infectives, Corticosteroids, NSAIDs, Allergy Agents, Lubricants, Supplements & Anti-VEGF

24 Chapter 24: Microbiology & Ocular Specimen Collection

24.1 Types of Microorganisms & Pathways of Disease Transmission 24.2 Assisting with Conjunctival & Corneal Specimen Collection

25 Chapter 25: Anterior Segment, Glaucoma & Refractive Surgery

25.1 Advanced Phacoemulsification, Surgical Steps, Fluidics & Complication Management 25.2 Premium Intraocular Lenses: Toric, Multifocal, EDOF & Lens Exchange 25.3 Glaucoma Surgical Procedures: Trabeculectomy, Aqueous Shunts & MIGS Devices 25.4 Laser In Situ Keratomileusis (LASIK), PRK, SMILE & Phakic IOLs

26 Chapter 26: Vitreoretinal, Corneal & Trauma Surgery

26.1 Pars Plana Vitrectomy (PPV), Scleral Buckling & Intraocular Tamponades (Gas/Silicone Oil) 26.2 Corneal Transplantation: Penetrating Keratoplasty (PKP) & Lamellar Keratoplasty (DSAEK, DMEK, DALK) 26.3 Ocular Trauma Repair: Open Globe Management, Hyphema, Vitreous Loss & Endophthalmitis Protocol

27 Chapter 27: Surgical Asepsis, Instrumentation & Laser Procedures

27.1 Operating Room Sterilization, Aseptic Field Maintenance & Universal Precautions 27.2 Microsurgical Instrumentation, Maintenance & Sharps Safety 27.3 Ophthalmic Laser Physics, Delivery Systems & Safety (Nd:YAG, Argon/FD-Nd:YAG, SLT)

28 Chapter 28: Ophthalmic Patient Services & Education

28.1 Communicating with Patients, Families and Colleagues, and Handling Dissatisfaction 28.2 Patient Education & Counselling on Conditions, Medications, Tests and Results 28.3 Ophthalmic Emergencies, First Aid, Vital Signs & CPR 28.4 Triage, Urgency-Based Scheduling, Patient Flow & Telephone Management 28.5 Dressings and Shields, Prosthetics, Legal Forms, Referrals & Reimbursement Support

29 Chapter 29: Clinic Operations — Equipment Maintenance, Ethics, Coding & Compliance

29.1 Equipment Maintenance, Calibration, Emergency Equipment & Inventory 29.2 Confidentiality, Informed Consent, Scope of Practice & Ethical Standards 29.3 Coding, Scribing Compliance, Quality Assurance & Regulatory Requirements

14.3 Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity

Key Takeaways Explain This Topic AI

Visual Evoked Potentials (VEP) record electrical post-synaptic activity in the primary visual cortex (Brodmann area 17/striate cortex), providing an objective electrophysiologic assessment of the entire visual pathway from retina to occiput.

The pattern-reversal VEP (PR-VEP) waveform features a prominent positive peak at approximately 100 ms (P100, normal ~90–110 ms), flanked by negative troughs at 75 ms (N75) and 145 ms (N145).

The cardinal electrophysiologic distinction in optic nerve disease: demyelinating optic neuritis causes marked P100 latency prolongation (>115–150 ms) with relatively preserved amplitude, whereas ischemic/compressive optic neuropathies (e.g., NAION) cause severe amplitude reduction with near-normal latency.

International 10-20 electrode placement mandates the active electrode at Oz (midline, 10% of nasion-inion distance above inion), reference at Fz, and ground at forehead/vertex; multi-channel montages (O1, Oz, O2) are vital for detecting chiasmal misrouting in ocular albinism.

Flash VEP (F-VEP) is indicated when optical opacities (dense mature cataract, vitreous hemorrhage) or poor patient cooperation preclude pattern viewing, assessing basic visual pathway continuity prior to anterior segment reconstruction or vitrectomy.

Last updated: September 2026

Visual Evoked Potentials (VEP): Flash, Pattern & Visual Pathway Integrity

Core Clinical Mandate: While electroretinography evaluates the retinal layers, it cannot evaluate post-retinal neuro-transmission. Visual Evoked Potentials (VEP)—also termed Visual Evoked Responses (VER) or Cortical Potentials (VECP)—measure the electroencephalographic activity of the visual cortex in response to light or patterned stimuli. VEP is the gold standard for objectively testing the functional integrity of the entire visual pathway from the photoreceptors through the optic nerve, chiasm, optic radiations, and primary visual cortex.

Functional Neuroanatomy and Cortical Magnification

To interpret VEP recordings, the technologist must understand how electrical signals travel through the intracranial visual pathways and project onto the occipital scalp: Retinal Ganglion Cells (Axons form RNFL)

  • └── Optic Nerve (CN II)
  • └── Optic Chiasm (Nasal fibers decussate 53%; temporal uncrossed 47%)
  • └── Optic Tract
  • └── Lateral Geniculate Nucleus (LGN in thalamus)
  • └── Optic Radiations (Geniculocalcarine tract via Meyer's & parietal loops)
  • └── Primary Visual Cortex (Striate Cortex, Area 17, Calcarine Fissure)
  • Cortical Magnification of the Central Macula

The primary visual cortex (Brodmann area 17, V1) is organized retinotopically along the banks of the calcarine fissure on the medial aspect of the occipital lobes.

Disproportionate Macular Representation: Although the macula covers only ~5% of the retinal surface area, axons originating from the central 5° to 10° of the retina project to and terminate upon more than 50% to 60% of the surface area of the primary visual cortex .

Superficial Occipital Pole Anatomy: Furthermore, the cortical neurons representing the central fovea are located on the most superficial, posterior-lateral aspect of the occipital pole , directly underlying the scalp. In contrast, the peripheral retina projects deep within the anterior calcarine fissure.

Clinical Significance: Because superficial dipoles dominate scalp electrical recordings, the conventional clinical VEP is overwhelmingly a reflection of central macular and optic nerve projection pathways .

Loading diagram... PR-VEP Diagnostic Decision Tree: Demyelinating vs Ischemic / Axonal Injury

ISCEV Standard VEP Modalities and Clinical Indications

The International Society for Clinical Electrophysiology of Vision defines three standard clinical VEP paradigms, alongside modern multifocal modalities:

1. Pattern-Reversal VEP (PR-VEP)

The Gold Standard: The preferred, most sensitive, and most reproducible clinical modality for evaluating optic nerve and pathway function in cooperative patients.

Stimulus: High-contrast black-and-white checkerboard pattern reversing at a rate of 2 reversals per second (1.0 Hz) .

Standard Check Sizes:

Large Checks (1.0° / 60 arcmin): Assesses broader pathway integrity and lower-spatial-frequency channels; less sensitive to mild refractive blur; essential for patients with subnormal acuity.

Small Checks (0.25° / 15 arcmin): Highly sensitive to subtle macular conduction delays, foveal pathways, and mild visual acuity deficits.

2. Pattern Onset / Offset VEP

Mechanism: A checkerboard pattern appears abruptly from a diffuse gray field of identical mean luminance for 100–200 ms, followed by return to the gray field for 400 ms.

Clinical Indications: Preferred in patients with ocular nystagmus , erratic involuntary saccades, or malingering suspects who intentionally defocus or move their eyes during pattern-reversal testing, as pattern onset/offset is significantly less vulnerable to motion artifacts.

3. Flash VEP (F-VEP)

Mechanism: A brief, high-intensity Ganzfeld or strobe flash (3.0 cd·s/m²) delivered to open or closed eyes.

Waveform Characteristics: A complex series of negative and positive peaks designated N1, P1, N2, P2, N3, with the most robust positive peak (P2) occurring at approximately 100 to 120 milliseconds .

Primary Indications:

Media Opacities: Severe corneal scarring, dense mature cataracts, or massive vitreous hemorrhage where pattern stimuli cannot form an optical image on the retina. A preserved F-VEP confirms that the underlying optic nerve and visual cortex are intact, providing critical prognostic clearance for surgery.

Uncooperative Patients: Infants, comatose patients, mentally impaired individuals, or intraoperative neuromonitoring during neurosurgical craniotomies.

Limitation: High normal inter-subject variability in amplitude and latency; cannot detect subtle conduction delays or minor scotomas.

4. Multifocal VEP (mfVEP)

Stimulates 60 to 120 cortically scaled sectors of the visual field using pseudorandom m-sequences (analogous to mfERG).

Creates a topographic map of cortical visual field responses, identifying localized optic nerve bundle defects (e.g., arcuate scotomas in glaucoma or optic neuritis) that are averaged out on full-field PR-VEP.

Waveform Architecture: The P100 Complex

The standard pattern-reversal VEP produces a triphasic, highly reproducible electrical waveform characterized by three distinct peaks: P100 Peak (~100 ms, Normal 90-110 ms)

  • /\
  • / \
  • / \
  • Baseline (0 µV) / \ /
  • ---------------/ \ /
  • \ / \ /
  • \ / \____/
  • \ / N145 Trough (~145 ms)
  • \/
  • N75 Trough (~75 ms)

N75 Trough: First negative deflection occurring at approximately 75 milliseconds (normal: 70 to 80 ms).

P100 Peak: The dominant, sharp positive peak occurring at approximately 100 milliseconds (normal reference range: 90 to 110 ms in healthy adults under 60 years of age).

Cellular Origin: Originates from post-synaptic excitatory potentials of pyramidal cells located in the primary visual cortex (striate and peristriate occipital cortex).

Clinical Metric: Peak latency (implicit time) is measured from the moment of pattern reversal ( T = 0 T = 0 T = 0 ) to the highest crest of the P100 wave. Peak-to-peak amplitude is measured from the preceding N75 trough to the P100 peak (normal: typically 5 to 20 µV).

N145 Trough: Broad negative deflection following P100, occurring at approximately 145 milliseconds (normal: 135 to 155 ms).

The Cardinal Diagnostic Rule: Latency Prolongation vs. Amplitude Attenuation

In neuro-ophthalmology, the pattern-reversal VEP provides an exceptional electrophysiologic discriminator between demyelinating and axonal/ischemic optic neuropathies:

Disease Category Primary Pathophysiology P100 Latency Impact P100 Amplitude Impact Classic Clinical Entities

Demyelinating Disease Loss of myelin sheath; breakdown of saltatory conduction Marked Prolongation (>115 to 160+ ms) Relatively preserved or mildly reduced Acute Optic Neuritis , Multiple Sclerosis (MS)

Ischemic Neuropathy Infarction of optic nerve axons; vascular compromise Normal or minimal delay (<110–115 ms) Severely Reduced / Extinguished NAION , Giant Cell Arteritis (AION)

Compressive Lesion Extrinsic mechanical tumor compression of optic nerve Progressive latency prolongation & amplitude drop Progressive reduction Pituitary adenoma, Meningioma, Craniopharyngioma

Toxic / Nutritional Mitochondrial dysfunction in papillomacular bundle Bilateral symmetrical latency delay & amplitude loss Moderate reduction Ethambutol, Methanol, Vitamin B12 deficiency

Acute Demyelinating Optic Neuritis and Multiple Sclerosis

Conduction Block and Saltatory Failure: In optic neuritis associated with multiple sclerosis, inflammatory demyelination strips the myelin sheath from oligodendrocytes along the optic nerve axons. Saltatory conduction fails, forcing continuous, slow electrical propagation along denuded axolemma.

P100 Latency Signature: This creates a dramatic delay in the P100 peak, frequently pushing latency beyond 125 to 150+ milliseconds .

The "Conduction Scar": Following clinical recovery, visual acuity typically returns to 20/20. However, remyelinated axons exhibit thinner myelin sheaths and shorter internodal distances. Consequently, the P100 latency delay remains permanently prolonged for years or decades , serving as an objective electrophysiologic "scar" that documents a prior subclinical demyelinating event.

Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION)

Axonal Death Without Conduction Delay: In NAION, acute hypoperfusion of the short posterior ciliary arteries causes ischemic infarction of optic nerve axons at the lamina cribrosa. Surviving nerve fibers remain normally myelinated.

P100 Signature: Because the surviving axons conduct at normal velocity, the P100 latency remains normal or only minimally delayed (<110–115 ms) . However, because a large proportion of axons have died, the total electrical signal arriving at the occipital cortex is depleted, causing profound amplitude reduction .

Electrode Montages: The International 10-20 System and Lateralization

Accurate VEP recording requires standardized scalp electrode placement based on cranial bony landmarks according to the International 10-20 System .

Single-Channel Standard Montage

Active Electrode (Oz): Positioned on the posterior midline of the scalp at a distance equal to 10% of the total nasion-inion distance (approximately 3 to 4 cm in adults) above the inion (external occipital protuberance). This places the electrode directly over the superficial occipital pole.

Reference Electrode (Fz): Positioned on the anterior midline of the scalp at 30% of the nasion-inion distance posterior to the nasion (frontal midline position).

Ground Electrode: Placed on the forehead (Fpz), vertex (Cz), or earlobe.

Multi-Channel Montage: O1, Oz, and O2 for Lateralization

To evaluate chiasmal and retrochiasmal lesions, a three-channel horizontal occipital array is deployed:

O1 (Left Occipital): Placed 5 cm lateral to Oz on the left.

O2 (Right Occipital): Placed 5 cm lateral to Oz on the right.

Reference (Fz): Common frontal reference. Horizontal Occipital Scalp Array (International 10-20 System):

  • [ Fz ] (Reference - Frontal Midline)
  • |
  • |
  • [ Cz ] (Vertex Ground)
  • |
  • |
  • [ O1 ] [ Oz ] [ O2 ] (10% above inion)
  • (Left Occipital) (Midline) (Right Occipital)
  • |
  • [ Inion ] (External Occipital Protuberance)
  • Chiasmal Misrouting in Ocular and Oculocutaneous Albinism

A celebrated application of multi-channel VEP is the definitive diagnosis of albinism in infants and young children:

Embryological Defect: In albinism (due to melanin deficiency in the developing optic chiasm), an abnormal proportion of temporal retinal ganglion cell axons aberrantly cross the midline at the chiasm instead of remaining uncrossed.

Contralateral Cortical Hemispheric Asymmetry: When the right eye is stimulated, the electrical signal abnormally crosses over to the left occipital cortex (O1), rather than distributing symmetrically across both hemispheres.

Diagnostic Finding: Monocular stimulation of each eye reveals a dramatic hemispheric asymmetry (asymmetric crossover) on the multi-channel lateral recording (O1 vs. O2), which reverses when the contralateral eye is tested. This electrophysiologic finding is pathognomonic for albinism and rules out simple idiopathic congenital nystagmus.

Clinical Assessment of Non-Organic (Functional) Visual Loss

Visual Evoked Potentials represent the gold standard objective legal and clinical examination for non-organic visual loss (malingering or conversion disorder):

Step-Down Check Size Paradigm

A patient claiming profound unilateral or bilateral visual loss (e.g., "I cannot see the big E on the chart, visual acuity 20/400") is seated before the pattern-reversal display.

The technologist presents sequentially smaller check sizes:

  • 60 arcmin checks (corresponds to ~20/200 visual resolution)
  • 30 arcmin checks (corresponds to ~20/100 visual resolution)
  • 15 arcmin checks (corresponds to ~20/50 visual resolution)
  • 7.5 arcmin checks (corresponds to ~20/20 to 20/25 visual resolution)

Objective Proof: If the patient generates a robust, normal-amplitude P100 waveform with normal latency when viewing 15 arcmin and 7.5 arcmin checks , this objectively proves that the visual pathway can resolve high-spatial-frequency information compatible with 20/20 to 20/25 visual acuity .

Detecting Deliberate Visual Defocus (Malingerer Counter-Strategies)

Cunning patients may attempt to defeat VEP testing by intentionally gazing beyond the monitor, squinting, or voluntary convergence/accommodation spasm to blur the checkerboard.

Technologist Detection: The technologist must watch the patient's pupils and gaze directly. Furthermore, if a patient deliberately defocuses, the VEP to small checks will extinguish, but the VEP to large (60 arcmin) checks will remain completely normal. Switching to a pattern onset/offset stimulus or administering a mild cycloplegic drop with exact trial frame correction eliminates accommodative defocusing.

  • Technologist Protocol, Patient Setup, and Artifact Control
  • Patient Setup Checklist

Monocular Testing Protocol: VEP testing must be performed monocularly . The non-tested eye must be securely covered with an opaque, light-tight patch. Binocular testing is reserved exclusively for evaluating binocular summation or specific strabismic suppression.

Pupils Undilated (No Mydriasis): Pupils must remain naturally undilated . Dilation reduces retinal illumination contrast, induces spherical aberrations, and abolishes depth of focus, artificially diminishing P100 amplitude and slightly delaying latency.

Refractive Correction at 1 Meter: The patient must wear their exact optical refraction adjusted for the calibrated test distance (typically 1.0 meter). An uncorrected error of even 1.50 D can extinguish responses to 15 arcmin checks.

Scalp Preparation and Low Impedance:

Part the hair meticulously and clean the scalp skin over Oz, Fz, and inion with an abrasive prepping gel (e.g., NuPrep) to strip sebum and dead epidermal layers.

Apply silver/silver chloride (Ag/AgCl) cup electrodes with conductive adhesive paste (e.g., Ten20).

Measure inter-electrode impedance: all skin impedances must be under 5 kΩ and balanced within 1 kΩ of each other to ensure high common-mode rejection.

Averaging and Sweep Parameters:

Record at least 100 to 200 artifact-free sweeps per trial.

Always run at least two independent consecutive trials per eye to demonstrate waveform reproducibility.